XOMA Corporation (XOMA)
USD 25.26
(-6.93%)
USD 25.26
(-6.93%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 124.45 Million USD | 365929.41% |
| 2022 | 34 Thousand USD | -85.15% |
| 2021 | 229 Thousand USD | -98.92% |
| 2020 | 21.26 Million USD | -35.28% |
| 2019 | 32.84 Million USD | 46.13% |
| 2018 | 22.47 Million USD | 54.26% |
| 2017 | 14.57 Million USD | -66.24% |
| 2016 | 43.16 Million USD | -11.3% |
| 2015 | 48.66 Million USD | 36.95% |
| 2014 | 35.53 Million USD | -13.29% |
| 2013 | 40.98 Million USD | -0.14% |
| 2012 | 41.04 Million USD | 22.43% |
| 2011 | 33.52 Million USD | 144.81% |
| 2010 | 13.69 Million USD | 2.65% |
| 2009 | 13.34 Million USD | -78.92% |
| 2008 | 63.27 Million USD | 24.43% |
| 2007 | 50.85 Million USD | -48.23% |
| 2006 | 98.21 Million USD | 63.69% |
| 2005 | 60 Million USD | 16897.17% |
| 2004 | 353 Thousand USD | -99.4% |
| 2003 | 59.32 Million USD | -15.64% |
| 2002 | 70.32 Million USD | 21.12% |
| 2001 | 58.05 Million USD | 45.02% |
| 2000 | 40.03 Million USD | 15.37% |
| 1999 | 34.7 Million USD | 29.48% |
| 1998 | 26.8 Million USD | 5.1% |
| 1997 | 25.5 Million USD | 73.47% |
| 1996 | 14.7 Million USD | 79.27% |
| 1995 | 8.2 Million USD | 1950.0% |
| 1994 | 400 Thousand USD | -60.0% |
| 1993 | 1 Million USD | -33.33% |
| 1992 | 1.5 Million USD | -21.05% |
| 1991 | 1.9 Million USD | -96.79% |
| 1990 | 59.2 Million USD | -23.02% |
| 1989 | 76.9 Million USD | 76800.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 121.92 Million USD | 0.73% |
| 2024 Q1 | 121.04 Million USD | -2.74% |
| 2023 FY | 124.45 Million USD | 365929.41% |
| 2023 Q1 | 69 Thousand USD | 102.94% |
| 2023 Q2 | 17 Thousand USD | -75.36% |
| 2023 Q3 | - USD | -100.0% |
| 2023 Q4 | 124.45 Million USD | 0.0% |
| 2022 Q4 | 34 Thousand USD | -60.0% |
| 2022 Q2 | 133 Thousand USD | -26.92% |
| 2022 Q1 | 182 Thousand USD | -20.52% |
| 2022 FY | 34 Thousand USD | -85.15% |
| 2022 Q3 | 85 Thousand USD | -36.09% |
| 2021 Q3 | 276 Thousand USD | -13.75% |
| 2021 FY | 229 Thousand USD | -98.92% |
| 2021 Q1 | 19.22 Million USD | -9.6% |
| 2021 Q4 | 229 Thousand USD | -17.03% |
| 2021 Q2 | 320 Thousand USD | -98.34% |
| 2020 Q2 | 31.58 Million USD | -1.49% |
| 2020 FY | 21.26 Million USD | -35.28% |
| 2020 Q3 | 30.4 Million USD | -3.74% |
| 2020 Q4 | 21.26 Million USD | -30.07% |
| 2020 Q1 | 32.06 Million USD | -2.39% |
| 2019 FY | 32.84 Million USD | 46.13% |
| 2019 Q3 | 40.22 Million USD | 17.86% |
| 2019 Q2 | 34.12 Million USD | 9.27% |
| 2019 Q4 | 32.84 Million USD | -18.33% |
| 2019 Q1 | 31.23 Million USD | 38.93% |
| 2018 FY | 22.47 Million USD | 54.26% |
| 2018 Q1 | 14.57 Million USD | 0.0% |
| 2018 Q4 | 22.47 Million USD | 2.02% |
| 2018 Q3 | 22.03 Million USD | 48.35% |
| 2018 Q2 | 14.85 Million USD | 1.93% |
| 2017 Q4 | 14.57 Million USD | 1.75% |
| 2017 FY | 14.57 Million USD | -66.24% |
| 2017 Q1 | 26.62 Million USD | -38.31% |
| 2017 Q2 | 27.86 Million USD | 4.63% |
| 2017 Q3 | 14.32 Million USD | -48.59% |
| 2016 Q1 | 46.25 Million USD | -4.96% |
| 2016 Q2 | 46.52 Million USD | 0.59% |
| 2016 Q4 | 43.16 Million USD | -4.54% |
| 2016 Q3 | 45.21 Million USD | -2.81% |
| 2016 FY | 43.16 Million USD | -11.3% |
| 2015 Q4 | 48.66 Million USD | 0.17% |
| 2015 FY | 48.66 Million USD | 36.95% |
| 2015 Q3 | 48.58 Million USD | 1.21% |
| 2015 Q2 | 48 Million USD | 1.73% |
| 2015 Q1 | 47.18 Million USD | 32.79% |
| 2014 Q1 | 38.74 Million USD | -5.47% |
| 2014 Q2 | 38.3 Million USD | -1.14% |
| 2014 Q3 | 36.58 Million USD | -4.48% |
| 2014 FY | 35.53 Million USD | -13.29% |
| 2014 Q4 | 35.53 Million USD | -2.87% |
| 2013 Q1 | 41.1 Million USD | 0.14% |
| 2013 Q4 | 40.98 Million USD | -0.1% |
| 2013 Q2 | 40.95 Million USD | -0.35% |
| 2013 Q3 | 41.02 Million USD | 0.16% |
| 2013 FY | 40.98 Million USD | -0.14% |
| 2012 Q2 | 35.47 Million USD | -2.45% |
| 2012 Q4 | 41.04 Million USD | 2.62% |
| 2012 Q3 | 39.99 Million USD | 12.76% |
| 2012 FY | 41.04 Million USD | 22.43% |
| 2012 Q1 | 36.36 Million USD | 8.47% |
| 2011 FY | 33.52 Million USD | 144.81% |
| 2011 Q1 | 26.24 Million USD | 91.62% |
| 2011 Q2 | 27.03 Million USD | 3.01% |
| 2011 Q3 | 26.64 Million USD | -1.41% |
| 2011 Q4 | 33.52 Million USD | 25.8% |
| 2010 Q3 | 13.5 Million USD | -0.04% |
| 2010 Q4 | 13.69 Million USD | 1.44% |
| 2010 Q1 | 13.34 Million USD | 0.0% |
| 2010 FY | 13.69 Million USD | 2.65% |
| 2010 Q2 | 13.5 Million USD | 1.23% |
| 2009 Q4 | 13.34 Million USD | 1.61% |
| 2009 Q1 | 63.27 Million USD | 0.0% |
| 2009 Q2 | 55.12 Million USD | -12.88% |
| 2009 Q3 | 13.12 Million USD | -76.18% |
| 2009 FY | 13.34 Million USD | -78.92% |
| 2008 Q3 | 76.3 Million USD | 0.05% |
| 2008 Q2 | 76.26 Million USD | 78.64% |
| 2008 Q1 | 42.69 Million USD | -16.05% |
| 2008 Q4 | 63.27 Million USD | -17.07% |
| 2008 FY | 63.27 Million USD | 24.43% |
| 2007 Q2 | 49.24 Million USD | 5.49% |
| 2007 Q4 | 50.85 Million USD | 3.25% |
| 2007 FY | 50.85 Million USD | -48.23% |
| 2007 Q3 | 49.24 Million USD | 0.0% |
| 2007 Q1 | 46.68 Million USD | -52.47% |
| 2006 Q3 | 74.19 Million USD | 0.39% |
| 2006 Q2 | 73.9 Million USD | -5.08% |
| 2006 Q1 | 77.86 Million USD | 29.77% |
| 2006 Q4 | 98.21 Million USD | 32.38% |
| 2006 FY | 98.21 Million USD | 63.69% |
| 2005 FY | 60 Million USD | 16897.17% |
| 2005 Q1 | 60.15 Million USD | 16941.36% |
| 2005 Q2 | 60.1 Million USD | -0.09% |
| 2005 Q3 | 68.89 Million USD | 14.62% |
| 2005 Q4 | 60 Million USD | -12.91% |
| 2004 FY | 353 Thousand USD | -99.4% |
| 2004 Q2 | 41.3 Million USD | -26.85% |
| 2004 Q3 | 48.11 Million USD | 16.5% |
| 2004 Q1 | 56.46 Million USD | -4.82% |
| 2004 Q4 | 353 Thousand USD | -99.27% |
| 2003 FY | 59.32 Million USD | -15.64% |
| 2003 Q1 | 77.37 Million USD | 10.03% |
| 2003 Q2 | 81.13 Million USD | 4.86% |
| 2003 Q3 | 83.36 Million USD | 2.76% |
| 2003 Q4 | 59.32 Million USD | -28.84% |
| 2002 Q2 | 64.78 Million USD | 9.46% |
| 2002 Q4 | 70.32 Million USD | 6.78% |
| 2002 FY | 70.32 Million USD | 21.12% |
| 2002 Q1 | 59.18 Million USD | 1.94% |
| 2002 Q3 | 65.85 Million USD | 1.65% |
| 2001 Q3 | 45.53 Million USD | 3.32% |
| 2001 Q4 | 58.05 Million USD | 27.52% |
| 2001 Q2 | 44.06 Million USD | 1.81% |
| 2001 Q1 | 43.28 Million USD | 8.12% |
| 2001 FY | 58.05 Million USD | 45.02% |
| 2000 FY | 40.03 Million USD | 15.37% |
| 2000 Q1 | 40.16 Million USD | 15.74% |
| 2000 Q3 | 36.23 Million USD | 7.7% |
| 2000 Q4 | 40.03 Million USD | 10.48% |
| 2000 Q2 | 33.64 Million USD | -16.22% |
| 1999 Q3 | 30.3 Million USD | -3.5% |
| 1999 Q4 | 34.7 Million USD | 14.52% |
| 1999 Q1 | 27.1 Million USD | 1.12% |
| 1999 FY | 34.7 Million USD | 29.48% |
| 1999 Q2 | 31.4 Million USD | 15.87% |
| 1998 FY | 26.8 Million USD | 5.1% |
| 1998 Q2 | 25.6 Million USD | 1.59% |
| 1998 Q4 | 26.8 Million USD | 2.68% |
| 1998 Q3 | 26.1 Million USD | 1.95% |
| 1998 Q1 | 25.2 Million USD | -1.18% |
| 1997 Q3 | 14.5 Million USD | 1.4% |
| 1997 Q4 | 25.5 Million USD | 75.86% |
| 1997 FY | 25.5 Million USD | 73.47% |
| 1997 Q2 | 14.3 Million USD | 2.14% |
| 1997 Q1 | 14 Million USD | -4.76% |
| 1996 Q1 | - USD | -100.0% |
| 1996 FY | 14.7 Million USD | 79.27% |
| 1996 Q3 | 5 Million USD | 0.0% |
| 1996 Q4 | 14.7 Million USD | 194.0% |
| 1996 Q2 | 5 Million USD | 0.0% |
| 1995 FY | 8.2 Million USD | 1950.0% |
| 1995 Q4 | 8.2 Million USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | -100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1994 Q4 | 400 Thousand USD | 0.0% |
| 1994 Q1 | - USD | -100.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | 400 Thousand USD | -60.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | -100.0% |
| 1993 FY | 1 Million USD | -33.33% |
| 1993 Q1 | 10.4 Million USD | 593.33% |
| 1993 Q4 | 1 Million USD | 0.0% |
| 1992 FY | 1.5 Million USD | -21.05% |
| 1992 Q2 | 1.3 Million USD | -7.14% |
| 1992 Q4 | 1.5 Million USD | 25.0% |
| 1992 Q1 | 1.4 Million USD | -26.32% |
| 1992 Q3 | 1.2 Million USD | -7.69% |
| 1991 FY | 1.9 Million USD | -96.79% |
| 1991 Q3 | 1.6 Million USD | -5.88% |
| 1991 Q4 | 1.9 Million USD | 18.75% |
| 1991 Q1 | 57.8 Million USD | -2.36% |
| 1991 Q2 | 1.7 Million USD | -97.06% |
| 1990 Q3 | 58.9 Million USD | -20.73% |
| 1990 Q1 | 75.3 Million USD | -2.08% |
| 1990 FY | 59.2 Million USD | -23.02% |
| 1990 Q2 | 74.3 Million USD | -1.33% |
| 1990 Q4 | 59.2 Million USD | 0.51% |
| 1989 Q2 | 78.8 Million USD | 0.0% |
| 1989 Q3 | 77.6 Million USD | -1.52% |
| 1989 Q4 | 76.9 Million USD | -0.9% |
| 1989 FY | 76.9 Million USD | 76800.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 45.757% |
| IO Biotech, Inc. | 2.49 Million USD | -4889.976% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -58054.206% |
| Organovo Holdings, Inc. | 1.39 Million USD | -8827.547% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -254555.208% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -75799.419% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1168.216% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1671.782% |
| Savara Inc. | 26.73 Million USD | -365.442% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -18337.037% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -396.965% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -495.904% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1437631.054% |
| Soligenix, Inc. | 3.49 Million USD | -3461.248% |
| Aptose Biosciences Inc. | 1 Million USD | -12224.149% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -524.718% |
| Century Therapeutics, Inc. | 48.17 Million USD | -158.35% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -197.421% |
| Precision BioSciences, Inc. | 31.26 Million USD | -298.011% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 33.225% |
| Kura Oncology, Inc. | 17.2 Million USD | -623.547% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -90786.518% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -34.638% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -4233.217% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -790.583% |
| Autolus Therapeutics plc | 52.96 Million USD | -134.958% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -2181.393% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -2175.553% |
| GRI Bio, Inc. | 14 Thousand USD | -888828.571% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -901.69% |
| IGM Biosciences, Inc. | 40.5 Million USD | -207.238% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 30.718% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2006.801% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -14951.207% |
| Opthea Limited | 200.62 Million USD | 37.97% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -113.534% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -115.044% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -994.355% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -1918.654% |
| Surrozen, Inc. | 3.37 Million USD | -3583.042% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -3869.572% |
| Ovid Therapeutics Inc. | 46 Million USD | -170.533% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | 7.475% |
| Acelyrin, Inc. | 1.19 Million USD | -10322.948% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -47.125% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -59439.757% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -311.868% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -100.483% |
| ADMA Biologics, Inc. | 141.41 Million USD | 11.998% |
| PureTech Health plc | 25.51 Million USD | -387.81% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -39035.22% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -7023.641% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -859.078% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -46.975% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -50284.615% |
| ChromaDex Corporation | 3.27 Million USD | -3697.681% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -19907.942% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 34.481% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -19.454% |
| Better Therapeutics, Inc. | 14.88 Million USD | -736.358% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -306.513% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -12.19% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -226.606% |
| Seer, Inc. | 28.25 Million USD | -340.391% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -1930.179% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -1871.329% |
| Gritstone bio, Inc. | 104.77 Million USD | -18.778% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4366.978% |
| Avid Bioservices, Inc. | 207.83 Million USD | 40.12% |
| Insmed Incorporated | 1.2 Billion USD | 89.664% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -2296.034% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -3088.573% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -20.2% |
| MediWound Ltd. | 6.71 Million USD | -1754.418% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -22.751% |
| Fortress Biotech, Inc. | 88.59 Million USD | -40.475% |
| OmniAb, Inc. | 25.56 Million USD | -386.875% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 41.828% |
| Zai Lab Limited | 15.15 Million USD | -721.398% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 73.988% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -292.191% |
| Veracyte, Inc. | 12.63 Million USD | -885.352% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -2204.63% |
| FibroGen, Inc. | 170.45 Million USD | 26.99% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -6018.489% |
| ContextLogic Inc. | 6 Million USD | -1974.167% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -78665.823% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -1797.393% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 97.853% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -82.398% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -336251.351% |
| ImmuCell Corporation | 11.96 Million USD | -939.743% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 92.583% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1600.834% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4366.978% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -176.108% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -188.286% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -175.113% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -158.04% |
| Vaxxinity, Inc. | 15.16 Million USD | -720.477% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 85.337% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -12013.125% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -876678.921% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -485.95% |
| Senti Biosciences, Inc. | 37.66 Million USD | -230.404% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -76570.959% |
| Apollomics, Inc. | 4.66 Million USD | -2570.028% |
| 89bio, Inc. | 27.1 Million USD | -359.09% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -8.057% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -27520.508% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1702.056% |
| Ardelyx, Inc. | 55.98 Million USD | -122.304% |
| Pluri Inc. | 29.61 Million USD | -320.269% |
| Prothena Corporation plc | 11.83 Million USD | -951.542% |
| Pulmatrix, Inc. | 8.75 Million USD | -1321.311% |
| Celularity Inc. | 65.41 Million USD | -90.241% |
| MeiraGTx Holdings plc | 89.26 Million USD | -39.418% |
| Omeros Corporation | 338.28 Million USD | 63.211% |
| Ainos, Inc. | 5.96 Million USD | -1986.842% |
| Humacyte, Inc. | 58.1 Million USD | -114.178% |
| Mesoblast Limited | 118.92 Million USD | -4.648% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -6616.136% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -2451.774% |
| Blueprint Medicines Corporation | 774.12 Million USD | 83.924% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -2380.072% |
| Summit Therapeutics Inc. | 106.09 Million USD | -17.296% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -101.317% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -7.893% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -294.478% |
| Cytokinetics, Incorporated | 755.77 Million USD | 83.533% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -829.842% |
| Nutriband Inc. | 241.28 Thousand USD | -51478.009% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -2176.386% |
| Roivant Sciences Ltd. | 499.74 Million USD | 75.097% |
| Evogene Ltd. | 1.13 Million USD | -10835.852% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -10050.897% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -225495.939% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 92.847% |
| BioLineRx Ltd. | 11.59 Million USD | -973.678% |
| Atai Life Sciences N.V. | 16.47 Million USD | -655.341% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -5770.283% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -27.501% |
| MediciNova, Inc. | 215.92 Thousand USD | -57535.486% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -4887.976% |
| MiMedx Group, Inc. | 48.09 Million USD | -158.737% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 70.014% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -3366.574% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -7511.621% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -152262.88% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1258.476% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -748.272% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -353.949% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -915.255% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -895.122% |
| Allakos Inc. | 41.46 Million USD | -200.133% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1050.079% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -82317.219% |
| BioAtla, Inc. | 2.46 Million USD | -4958.943% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -30.833% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -2143.96% |
| Precigen, Inc. | 7.09 Million USD | -1653.558% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -557.318% |
| Incyte Corporation | 38.28 Million USD | -225.045% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -188.299% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1017.346% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 47.849% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -377.864% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -35559.026% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -38017.203% |
| UroGen Pharma Ltd. | 100.21 Million USD | -24.184% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 31.901% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -35832.691% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -40703.279% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1720.775% |
| Chimerix, Inc. | 2.14 Million USD | -5704.571% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -250.018% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -71972.646% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -369.392% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -264687.234% |
| OncoCyte Corporation | 2.86 Million USD | -4237.748% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -9478.854% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -582803.981% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -82561.371% |
| Purple Biotech Ltd. | 351 Thousand USD | -35355.84% |
| NextCure, Inc. | 6.6 Million USD | -1784.179% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -27.127% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -2279.086% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 45.7% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -12756.405% |
| NLS Pharmaceutics AG | 1.63 Million USD | -7517.463% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | 55.654% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -4354.188% |
| Daré Bioscience, Inc. | 5.31 Million USD | -2240.102% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -21926.549% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -176.826% |
| BeiGene, Ltd. | 930.18 Million USD | 86.621% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -700.708% |
| Alector, Inc. | 38.91 Million USD | -219.775% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -10807.099% |
| Erasca, Inc. | 55.85 Million USD | -122.793% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -536.345% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -386.97% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -31647.287% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 89.024% |
| Histogen Inc. | 4.62 Million USD | -2592.557% |
| Fortress Biotech, Inc. | 88.59 Million USD | -40.475% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1163.195% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -97.017% |
| Galecto, Inc. | 249 Thousand USD | -49879.92% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 80.701% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 10.487% |
| Molecular Templates, Inc. | 12.23 Million USD | -917.58% |
| PDS Biotechnology Corporation | 23.85 Million USD | -421.768% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -2837.22% |
| Amarin Corporation plc | 8.73 Million USD | -1324.402% |
| TG Therapeutics, Inc. | 110.79 Million USD | -12.325% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2205.911% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -4795.751% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -560.107% |
| Onconetix, Inc. | 9.88 Million USD | -1158.88% |
| MacroGenics, Inc. | 33.97 Million USD | -266.342% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -8670.261% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -457.9% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 40.778% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1036.011% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -513.266% |
| SciSparc Ltd. | 76 Thousand USD | -163650.0% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -51.737% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -37726.748% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -391.936% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 39.563% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -132.765% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 95.361% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -1525.226% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -197439.683% |
| 2seventy bio, Inc. | 256.67 Million USD | 51.514% |
| Clene Inc. | 32.16 Million USD | -286.959% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -5569.704% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -60931.528% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1327.015% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -679.909% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -623.673% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -362.966% |
| Entera Bio Ltd. | 390 Thousand USD | -31810.256% |
| Trevena, Inc. | 35.23 Million USD | -253.22% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -393.164% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -352.792% |
| INmune Bio, Inc. | 10.43 Million USD | -1092.392% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -25760.009% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -1815.794% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -303436.585% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -361.097% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -24745.13% |
| Jaguar Health, Inc. | 35.86 Million USD | -247.044% |
| Clearside Biomedical, Inc. | 43 Million USD | -189.412% |
| NexImmune, Inc. | 68.8 Thousand USD | -180762.969% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -26663.441% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -10065.607% |
| Kronos Bio, Inc. | 28.27 Million USD | -340.188% |
| Innoviva, Inc. | 449.07 Million USD | 72.288% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 74.118% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 95.396% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -515.51% |
| Verastem, Inc. | 41.55 Million USD | -199.468% |
| ProKidney Corp. | 4.41 Million USD | -2720.077% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -7903.215% |
| Imunon, Inc. | 1.62 Million USD | -7559.81% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -9776.984% |
| Statera Biopharma, Inc. | 16.26 Million USD | -665.322% |
| ImmunityBio, Inc. | 883.67 Million USD | 85.917% |
| Korro Bio, Inc. | 33.2 Million USD | -274.77% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 69.255% |
| Kineta, Inc. | 1.31 Million USD | -9349.506% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -3398.735% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -2117.509% |
| GT Biopharma, Inc. | 58 Thousand USD | -214468.966% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -761.603% |
| Celularity Inc. | 65.41 Million USD | -90.241% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -140.585% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -405.463% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -75.341% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -12.769% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -32393.473% |
| Kodiak Sciences Inc. | 181.63 Million USD | 31.482% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -19.553% |
| Annexon, Inc. | 31.35 Million USD | -296.906% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -65.854% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -5213.834% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1699.19% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -798.556% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 91.438% |
| Vor Biopharma Inc. | 35.66 Million USD | -248.99% |
| Eyenovia, Inc. | 16.1 Million USD | -672.609% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -31012.5% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -11.624% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -170.314% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -287.477% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -12534.518% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -117.551% |
| Immunocore Holdings plc | 84.03 Million USD | -48.098% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -219.758% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -73.312% |
| Alkermes plc | 290.73 Million USD | 57.194% |
| Arcellx, Inc. | 97.62 Million USD | -27.478% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -4977.528% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -171.885% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -191361.538% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -3911.928% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -9768.932% |
| Moolec Science SA | 2.64 Million USD | -4604.59% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1108.722% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -44.879% |
| Mereo BioPharma Group plc | 5.95 Million USD | -1990.894% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -173.456% |
| Royalty Pharma plc | 6.13 Billion USD | 97.972% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -5081.099% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -7369.988% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -107878.899% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -267.869% |
| Humacyte, Inc. | 58.1 Million USD | -114.178% |
| Structure Therapeutics Inc. | 5.45 Million USD | -2182.23% |
| NLS Pharmaceutics AG | 1.63 Million USD | -7517.463% |
| Genelux Corporation | 2.51 Million USD | -4840.453% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -154827.298% |
| aTyr Pharma, Inc. | 15.09 Million USD | -724.445% |
| Notable Labs, Ltd. | 2.04 Million USD | -5973.694% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -41284.837% |
| Mustang Bio, Inc. | 2.49 Million USD | -4881.986% |
| Immunovant, Inc. | 138 Thousand USD | -90081.159% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -7526.898% |
| Vericel Corporation | 88.14 Million USD | -41.191% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 91.699% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -325.849% |
| Orgenesis Inc. | 22.62 Million USD | -450.153% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -2600.152% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -61205.419% |
| GH Research PLC | 343 Thousand USD | -36182.799% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -502.343% |
| PepGen Inc. | 20.1 Million USD | -519.031% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -21581.185% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -123117.822% |
| Belite Bio, Inc | 886 Thousand USD | -13946.275% |
| Pharming Group N.V. | 171.54 Million USD | 27.453% |
| XOMA Corporation | 124.45 Million USD | 0.0% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -12690.339% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 48.063% |
| Xencor, Inc. | 83.43 Million USD | -49.16% |
| Replimune Group, Inc. | 75.86 Million USD | -64.033% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -483.423% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1223.373% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -3772.122% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -639.453% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -5048.945% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -9768.932% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -110032.743% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -11959.109% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -3839.538% |
| scPharmaceuticals Inc. | 40.26 Million USD | -209.047% |
| HilleVax, Inc. | 51.19 Million USD | -143.1% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -131.716% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1270.444% |
| Immunic, Inc. | 1.33 Million USD | -9229.085% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -3601.229% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -30780.893% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1270.444% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -5725.086% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -643.829% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -5688.372% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 72.037% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -42866.687% |
| bluebird bio, Inc. | 330.32 Million USD | 62.325% |
| DBV Technologies S.A. | 14.38 Million USD | -765.378% |
| Compugen Ltd. | 1.35 Million USD | -9111.695% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -1060.719% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -4874.021% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -1904.671% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -7277.001% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -191.002% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -2579.802% |
| Benitec Biopharma Inc. | 284 Thousand USD | -43720.423% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -47.182% |
| Adicet Bio, Inc. | 20.92 Million USD | -494.772% |
| Prime Medicine, Inc. | 13.63 Million USD | -812.859% |
| Aditxt, Inc. | 18.21 Million USD | -583.116% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -6.192% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -713.239% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -15294.569% |
| PolyPid Ltd. | 11.77 Million USD | -956.541% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -36.073% |
| Invivyd, Inc. | 2.16 Million USD | -5648.268% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -3531668.893% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -105.434% |
| CorMedix Inc. | 667.63 Thousand USD | -18540.509% |
| Instil Bio, Inc. | 86.05 Million USD | -44.618% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -145.599% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 35.582% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -313.098% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -2145.174% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -837.406% |
| AbCellera Biologics Inc. | 77.38 Million USD | -60.83% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -49.24% |
| Surrozen, Inc. | 3.37 Million USD | -3583.042% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -407.09% |
| Verona Pharma plc | 51.32 Million USD | -142.456% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -20538.474% |
| Vir Biotechnology, Inc. | 124.54 Million USD | 0.072% |
| Evaxion Biotech A/S | 10.86 Million USD | -1044.928% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -66.139% |
| Shattuck Labs, Inc. | 4.2 Million USD | -2861.685% |
| AlloVir, Inc. | 27.42 Million USD | -353.717% |
| BioVie Inc. | 6.11 Million USD | -1936.343% |
| Codexis, Inc. | 22.36 Million USD | -456.475% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -13636.203% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -75799.419% |
| Agenus Inc. | 350.24 Million USD | 64.468% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -55383.727% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -52976.926% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -491.268% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -540.01% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -232.343% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -5691.066% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -336.866% |
| IN8bio, Inc. | 4.89 Million USD | -2443.429% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -9201.196% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -17.335% |
| Liquidia Corporation | 3.5 Million USD | -3452.669% |
| Quantum-Si incorporated | 15.3 Million USD | -713.239% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -152262.88% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1041.429% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -7428.736% |
| United Therapeutics Corporation | 700 Million USD | 82.221% |
| Solid Biosciences Inc. | 26.26 Million USD | -373.824% |
| Immuneering Corporation | 4.46 Million USD | -2688.509% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -837.406% |
| uniQure N.V. | 138.4 Million USD | 10.085% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -986.235% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -45.687% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -26100.0% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -836.7% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -59024.23% |
| Cue Biopharma, Inc. | 14.69 Million USD | -746.887% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -45319.708% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -312.948% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -12534.518% |
| Immunome, Inc. | 1.65 Million USD | -7442.424% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -7081.189% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1172.755% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -311.96% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -34278.453% |
| Altimmune, Inc. | 671 Thousand USD | -18446.945% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -140.367% |
| Rallybio Corporation | 392 Thousand USD | -31647.449% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -2876.561% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -21173.504% |
| Moolec Science SA | 2.64 Million USD | -4604.59% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -29887.952% |
| NeurAxis, Inc. | 224.26 Thousand USD | -55393.623% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 79.631% |
| Lumos Pharma, Inc. | 6.58 Million USD | -1789.901% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1172.755% |
| 180 Life Sciences Corp. | 1.32 Million USD | -9327.537% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -524.718% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -628.625% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -7903.215% |
| Nutriband Inc. | 241.28 Thousand USD | -51478.009% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -14966.586% |
| argenx SE | 20 Million USD | -522.25% |
| Neurogene Inc. | 16.25 Million USD | -665.611% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 59.613% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -336.039% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -598.608% |
| Design Therapeutics, Inc. | 3.05 Million USD | -3980.328% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -47400.0% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -774.684% |
| Achilles Therapeutics plc | 4.61 Million USD | -2596.641% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -87540.845% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1118.545% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 66.7% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -313.469% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -3265.455% |
| Palisade Bio, Inc. | 369 Thousand USD | -33626.287% |
| Beam Therapeutics Inc. | 173.17 Million USD | 28.135% |
| AEON Biopharma, Inc. | 278 Thousand USD | -44666.187% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -37049.254% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -116327.014% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -64.048% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -103.659% |
| Athira Pharma, Inc. | 1.58 Million USD | -7751.735% |
| Vaccinex, Inc. | 247 Thousand USD | -50284.615% |
| HCW Biologics Inc. | 6.45 Million USD | -1828.926% |
| XOMA Corporation | 124.45 Million USD | 0.0% |
| Nektar Therapeutics | 230.4 Million USD | 45.985% |
| Arvinas, Inc. | 3.4 Million USD | -3560.294% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -7526.898% |
| Merus N.V. | 12.16 Million USD | -923.269% |
| Omega Therapeutics, Inc. | 128.42 Million USD | 3.097% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -800.898% |
| Rezolute, Inc. | 2.22 Million USD | -5485.727% |
| Clene Inc. | 32.16 Million USD | -286.959% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -70992.755% |
| BeyondSpring Inc. | 3.99 Million USD | -3015.144% |
| Synlogic, Inc. | 17.27 Million USD | -620.405% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -9473.077% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -355471.429% |
| Peak Bio, Inc. | 10.72 Million USD | -1060.719% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -139.682% |
| Krystal Biotech, Inc. | 8.09 Million USD | -1437.559% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 29.696% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1663.497% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -91009.419% |
| MannKind Corporation | 382.37 Million USD | 67.454% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1058.968% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -30327.873% |
| Gossamer Bio, Inc. | 212.46 Million USD | 41.425% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -71422.989% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1258.476% |
| Legend Biotech Corporation | 328.67 Million USD | 62.136% |
| Mural Oncology plc | 15 Million USD | -729.169% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -162.409% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -5823.37% |
| Champions Oncology, Inc. | 7.43 Million USD | -1574.966% |
| REGENXBIO Inc. | 89.29 Million USD | -39.377% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -14460.716% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -22405.253% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -2198.67% |
| Vaxart, Inc. | 26.51 Million USD | -369.375% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -694.834% |
| Cellectis S.A. | 92.85 Million USD | -34.029% |
| Longeveron Inc. | 2.04 Million USD | -5997.501% |
| Repare Therapeutics Inc. | 3.41 Million USD | -3549.56% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 91.09% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -167.106% |
| Revolution Medicines, Inc. | 87.94 Million USD | -41.511% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -71836.416% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -3048.242% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -39158.675% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -71014.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 84.605% |
| Denali Therapeutics Inc. | 52.24 Million USD | -138.223% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -763.908% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -8957.496% |
| Cingulate Inc. | 3.13 Million USD | -3869.572% |
| Passage Bio, Inc. | 26.29 Million USD | -373.302% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -1767.217% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -30402.451% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -13820.582% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -41.511% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -505.272% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -9776.984% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -4977.269% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -3884.95% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -15245.253% |
| OmniAb, Inc. | 25.56 Million USD | -386.875% |
| Anew Medical, Inc. | 1.6 Million USD | -7653.894% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -320.683% |
| Lipocine Inc. | 17.16 Thousand USD | -724879.611% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -969.342% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -259.391% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2006.801% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -117.673% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -61205.419% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -2309.487% |
| Ocugen, Inc. | 6.94 Million USD | -1692.969% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -780.813% |
| Q32 Bio Inc. | 1.31 Million USD | -9342.337% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -18419.345% |
| Alumis Inc. Common Stock | 32.58 Million USD | -281.983% |
| Equillium, Inc. | 824 Thousand USD | -15003.155% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1270.746% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -41272.18% |
| Galera Therapeutics, Inc. | 152.29 Million USD | 18.286% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -143.361% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -15957.07% |
| Dominari Holdings Inc. | 3.02 Million USD | -4009.974% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -131611.241% |
| vTv Therapeutics Inc. | 529 Thousand USD | -23425.52% |
| Bio-Techne Corporation | 419.53 Million USD | 70.336% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -72.857% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 35.707% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -636.914% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -446.745% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -1954.308% |
| Nkarta, Inc. | 88.33 Million USD | -40.878% |
| BioCardia, Inc. | 1.31 Million USD | -9363.878% |
| Iterum Therapeutics plc | 19.5 Million USD | -537.911% |